If you need help managing stress, talk to your primary care physician
Most clinical applications remain exploratory, and long-term safety data in specific populations is insufficient
CagriSema trial dosing only, with no approved label
4.2 Treatment of microbiota dysbiosis and systemic diseases A growing body of evidence highlights the significant therapeutic potential of various interventions targeting the oral-gut axis to mitigate the local and systemic consequences of periodontitis
Supplementation with B12 may be advised for these groups, and it can be administered orally, through fortified foods, or by injection in cases where absorption may be impaired
This restriction applies regardless of body weight, metabolic status, or how well other treatments might work